Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome.

Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome.

Mouhayar, Elie N; Hammond, Danielle; Lopez-Mattei, Juan; Banchs, Jose; Konopleva, Marina; Pemmaraju, Naveen.

Afiliação

Mouhayar EN; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lopez-Mattei J; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Banchs J; Department of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

JACC CardioOncol ; 3(5): 752-755, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34988487

Palavras-chave

BPDCN, blastic plasmacytoid dendritic cell neoplasm; CLS, capillary leak syndrome; CMR, cardiovascular cardiac magnetic resonance; DT, diphtheria toxin; ECV, extracellular volume; EF, ejection fraction; LV, left ventricular; NT-proBNP, N-terminal proB-type natriuretic peptide; blastic plasmacytoid dendritic cell neoplasm; capillary leak syndrome; myocardial edema; tagraxofusp

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article